The Company
Our Expertise
Press Releases
Awards & Grants
Corporate Responsibility
Working at Debiopharm
Drug Development
At a glance
Pipeline
Products
Publications
Leadership Team
Debiopharm Innovation Fund
At a Glance
Approach
Portfolio
News
Team
Contact
Manufacturing, Research & Development
At a Glance
Technology pipeline
Leadership Team
Awards & Grants
Corporate Responsibility
Careers
Press Releases
Media
Manage cookies
Our parent company
Contact us
Home
Latest news
Latest news
Filters
(1)
Clear all
ABAC
AbYlink
Acteon
afabicin (Debio 1450)
afabicin (Debio 1450) ABSSSI
afabicin (Debio 1450) Bone & joint infections
altis labs
Antibody Drug Conjufates
Aspen
Award
BC Platforms
Biocartis
Campus après-demain
CARB-X
Carbonex
CDiff
Challenge Debiopharm-Inartis
Clinical Trials
Coorpacademy
CPP
cyclosporin A
Debio 0123
Debio 0228
Debio 025
Debio 0328
Debio 0432
Debio 0507
Debio 0513
Debio 0517
Debio 0532
Debio 0614 (istaroxime)
Debio 0615
Debio 0617
Debio 0633
Debio 0719
Debio 0824
Debio 0826
Debio 0827
Debio 0928
Debio 0929
Debio 0930
Debio 0931
Debio 0932 NSCLS
Debio 0932 RCC
Debio 1036
Debio 1124
Debio 1124 SCLC
Debio 1141
Debio 1142
Debio 1143
Debio 1143 Head & neck cancer
Debio 1143 NSCLC
Debio 1143 Ovarian cancer
Debio 1143 selected solid tumors
Debio 1143 with pembrolizumab
Debio 1144
Debio 1347
Debio 1348
Debio 1449
Debio 1453
Debio 1454
Debio 1454S
Debio 1460
Debio 1561
Debio 1562
Debio 4126
debio 4326
Debio 8206 SC
Debio 8609 Sanvar
Debio 9902 - ZT-1
Debiopharm Academy
Debiopharm Chair in Family Philanthropy
Debiopharm Life Sciences Award
Debiovision
Degraducer
Dexa Medica
Diagnoplex
EPFL
EPI-hNE4
FibroTrap
Fosanis
fuze
Galiena Capital
genepoc
genialis
Groupe Bertrand
H3 Pharma
Haut-Lac
HES-SO
Huperzine-A
IDEAL
Iktos
Immunexpress
InnoCentive
Japanese Cancer Research Association
JCA-Mauvernay Award
Kaiku Health
KeyLemon
little green house
MedaSystems
Mekonos
Moapar
Multilink
Muscular Dystrophy
naratuximab emtansine (Debio 1562)
NeoVacs
Novadiscovery
nucleai
Oncolifestyle
Oncology Chair
oncomfort
Oxaliplatin
paper.li
PLGA
Prix Debiopharm/Valais
revogene
Skiioo
Spinomix
Strategikon
Swiss Biotech Association
Téléthon
Tremelimumab
Triptorelin
VeriSIM Life
VivoSense
Wazoku
WhiteLab Genomics
xevinapant
YonaLink
Cancel
Validate
June 16, 2015
Debiopharm International SA acquires FibroTrap sample processing technology from Spinomix
Read more